Evidence map›Paper›PMID 34279775›Full record

ArticleActa parasitologica2022

Single-Nucleotide Polymorphism Associates' β-Tubulin Isotype-1 Gene in Onchocerca volvulus Populations in Ivermectin-Treated Communities in Taraba State, Nigeria.

Danlami E Akafyi, Iliya S Ndams, Ishaya H Nock, Gloria Chechet, Alfons Renz

Abstract read
PubMed Publisher
In one paragraph

Article in Acta parasitologica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Danlami E AkafyiDepartment of Zoology, Ahmadu Bello University, Zaria, Nigeria. dakafyi@yahoo.com.ORCID http://orcid.org/0000-0003-4120-5814
Iliya S NdamsDepartment of Zoology, Ahmadu Bello University, Zaria, Nigeria.
Ishaya H NockDepartment of Zoology, Ahmadu Bello University, Zaria, Nigeria.
Gloria ChechetDepartment of Biochemistry, Ahmadu Bello University, Zaria, Nigeria.
Alfons RenzInstitute for Evolution and Ecology, University of Tübingen, Tübingen, Germany.
Ahmadu Bello University · NGUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe occurrence of Single-Nucleotide Polymorphisms (SNPs) associated with repeated ivermectin treatment and sub-optimal responses reported by previous findings is of great concern in Onchocerciasis endemic areas. This study investigated SNPs' occurrence after 15 years of ivermectin intervention in Onchocerciasis endemic communities in two Local Government Areas of Taraba State, Nigeria.

methodsMicrofilariae samples were collected by skin snip from individuals treated with ivermectin for 10-15 years of annual distribution and preserved in RNAlater

resultsThree distinct SNP positions: 1183 (T/G), 1188 (T/C) and 1308 (C/T) on the β-tubulin gene on the targeted 1083-1568 bp fragment, associate's with the ivermectin-treated population. Furthermore, SNPs positions detected in this study are 1730 (A/G) and 1794 (T/G) in the β-tub gene in the 1557-1857 (bp) region. The 1794 (T/G) SNP position (Phe243Val) in the exon within the β-tubulin gene region were observed in this study.

conclusionThe present study indicates that SNPs are observed in Onchocerca volvulus, thus strengthening the warning that genetic changes could occur in some parasite populations in some ivermectin-treated areas.

Indexed as

Onchocerca volvulusOnchocerciasisAnimalsHumansIvermectinMicrofilariaeNigeriaOnchocercaPolymorphism, Single NucleotideTubulinIvermectinTubulinIvermectinMicrofilariaOnchocerciasisSnpsβ-tubulin

Identifiers

PMID34279775
OpenAlexW3183622678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.